HBV and targeted synthetic (ts)DMARDs: what have we learned from bDMARDs and tsDMARDs?

• Gerd Burmester,
• Josef S Smolen,
• Masayoshi Harigai,
• Kevin Winthrop,
• Yi-Ming Chen,
• Tsu-Yi Hsieh,
• Chad Walls,
• Wen-Shuo Wu,
• Christina Dickson,
• Ran Liao

Affiliations

Gerd Burmester

Rheumatology and Clinical Immunology, Charité University Hospital, Berlin, Germany

Josef S Smolen

Division of Rheumatology, Department of Medicine 3, Medical University of Vienna, Vienna, Austria

Masayoshi Harigai

Department of Rheumatology, Tokyo Women’s Medical University School of Medicine, Shinjuku-ku, Japan

Kevin Winthrop

8 Oregon Health & Science University School of Medicine, Portland, Oregon, USA

Yi-Ming Chen

Tsu-Yi Hsieh

Chad Walls

Wen-Shuo Wu

Christina Dickson

Eli Lilly and Company, Indianapolis, Indiana, USA

Ran Liao